The natural history of intracavitary aspergilloma, which is caused by the ubiquitous fungus Aspergillus fumigatus, remains unknown. Many reports, however, indicate that this opportunistic fungus colonises cavities in the upper lobes that result from pulmonary tuberculosis, lung cyst, lung abscess, bronchiectasis, neoplasms,' 3 sarcoidosis, and ankylosing spondylitis.4 5 The saprophyte forms a conglomeration of fragmented hyphae, fibrin, and inflammatory cells (called an aspergilloma, fungus ball, or mycetoma) with the radiological appearance of a crescent of air separating the mycetoma from the wall of the cavity. ' 6-8 Patients who have old tuberculous cavities with superimposed aspergillomas tend to have recurrent and life threatening haemoptysis,5 '9-4 and this is clearly an important factor to be considered in assessing their need for surgery. Consequently, this study was undertaken to review our experience of the incidence, natural history, diagnosis, and management of pulmonary aspergilloma seen in residual tuberculous cavities in a chest clinic serving a rural and urban population where pulmonary tuberculosis is endemic. This represents the largest published series from a single institution in our geographical zone.
Patients
Of 1345 patients with pulmonary tuberculosis seen in the chest clinic of the University of Ife Teaching Hospital, Ile-Ife, Nigeria, from January 1977 to September 1983, 11 were admitted with pulmonary aspergilloma (table 1) . Ages ranged from 29 years to 61 years. There were seven men and four women. The chest radiograph was available for review in all cases and figures 1-5 are representative of the group. Table 2 summarises the important clinical features in the 11 patients with aspergilloma associated with pulmonary tuberculosis. The duration of illness until presentation at the hospital ranged from one week to one and half years and the most frequent complaint was of recurrent haemoptysis, usually of one to two days' duration. Fever, productive cough, weight loss, and repeated haemoptysis with varying degrees of anaemia occurred in all patients. Five of the patients with severe or advanced pulmonary tuberculosis presented with dyspnoea and fatigue. There were four cases of finger clubbing.
Clinical manifestations

Diagnosis
Acid fast bacilli were present in the sputum smear of nine of the 11 patients and the remaining two had Management ofpulmonary aspergilloma in the presence of active tuberculosis Treatment and outcome Management ofpulmonary aspergilloma in the presence of active tuberculosis of streptomycin for three months and oral administration of a combination of isoniazid with either aminosalicylic acid or ethambutol or rifampicin for 18 to 24 months. Supportive blood transfusion was given to those who had a packed cell volume below 025. The surgical treatment consisted of either lobectomy (nine patients) or pneumonectomy (one patient) whenever the patient was physically fit for anaesthesia, since nearly all the lobes habouring the aspergilloma had been destroyed by the concurrent tuberculosis. One patient had left pneumonectomy (fig 2) because the left lung was completely fibrosed and studded with tubercles. The only patient with bilateral aspergillomas (fig 4) was scheduled to have staged resection but had only left upper lobectomy when she had a fatal haemoptysis on the sixth postoperative day. The eleventh patient, who refused to have surgery despite recurrent haemoptysis, eventually died at home after a massive haemoptysis. The postoperative complications included wound infection and empyema thoracis, which were treated effectively by the administration of appropriate antibiotics. Intrapleural instillation of antibiotics to which the organisms were sensitive combined with tidal irrigation of the infected pleural cavity with normal saline solution helped in reducing the postoperative morbidity.
Discussion
Aspergillus fumigatus is the most common cause of human aspergillosis and pulmonary aspergilloma. ' 4 7 The natural history of intracavitary aspergilloma is not well documented but the published data indicate that intracavitary aspergilloma results from saprophytic colonisation of areas of lung tissue that have been destroyed by sarcoidosis,4 tuberculosis, bronchiectasis, lung abscesses, and neoplasms.' 3 Israel and Ostrow4 in 1969 documented the association of sarcoidosis and aspergilloma in the chronic cystic cavities of upper lobes in patients with pulmonary sarcoidosis. Despite the frequent occurrence of pulmonary sarcoidosis in black Americans, it is not a common pulmonary disease in our environment.
The establishment of a definitive diagnosis of aspergillosis, from either sputum or tissue culture is often fraught with difficulty because airborne Aspergilli spores, being ubiquitous, commonly produce laboratory contamination and the role of A fumigatus as a pathogen is often overlooked.' [17] [18] [19] The fungus was recovered from the sputum in only four of our 11 cases. This low recovery rate is likely to be due to the mycetoma' s intracavitary location and its non-communication with the bronchus, as previously suggested.' 677 The sputum tests were positive for Mycobacterium tuberculosis from a smear in nine cases and from culture in two cases. This high incidence of positivity for acid fast bacilli was due to the fact that all patients still had active tuberculosis disease.
Most lesions are unilateral but isolated instances of multiple bilateral aspergillomas have been recorded.8 H 21 Our case of a 47 year old woman (No 8 in table 1) complements the list of the few reported cases of bilateral pulmonary aspergilloma in English publications.
The mainstay of treatment in all our cases consisted of combined preoperative and postoperative antituberculosis treatment, correction of anaemia, and subsequent surgical resection of the lobe housing the aspergilloma, provided that the pulmonary state and the clinical condition of the patient did not preclude surgery. Lobectomy or pneumonectomy was preferred to segmental resection, in the hope of forestalling pleural contamination with aspergilli that could lead to recurrent fungal infection in the form of empyema and bronchopleurocutaneous fistula, which may be refactory to all forms of treatment. 2 We share the view of others that surgical resection of the affected lobe is the treatment of choice for aspergilloma coexisting with pulmonary tuberculosis,2 11 1522 particularly because of the high incidence of exsanguinating haemoptysis in untreated cases.
Henderson and Pearson23 treated three cases of pulmonary aspergilloma by local surgical evacuation of the cavity followed by irrigation of the cavity with natamycin. These patients, however, had had prior treatment with intrabronchial instillations of natamycin without any benefit. Amphotericin B is still acclaimed as the most effective antifungal antibiotic available for invasive aspergillosis24 but its effect on pulmonary aspergilloma is still in doubt. A In view of the suddenness with which haemoptysis may occur in patients who have superimposed aspergillomas in tuberculous cavities, we support the conclusions of earlier reports" 1522 that recommend "prophylactic" resection of asymptomatic pulmonary aspergillomas. Of our two patients who had fatal haemoptysis, one had refused surgery in conjunction with the antituberculosis drug treatment despite repeated episodes of haemoptysis and the other had bilateral multiple aspergillomas and died before her staged resection could be completed.
Pulmonary resection for aspergilloma is rarely followed by complications attributable to the A fumigatus provided that lobar resection is performed to prevent the pleural dissemination that frequently occurs with segmental resection. The complication rate in cases with a well localised mycetoma is extremely low. Most of the surgical complications occur in debilitated, anaemic, and elderly patients. The surgical complications of wound infection and empyema thoracis which occurred in our series were in patients debilitated by their disease and age (table 1). These were managed by the administration of appropriate antibiotics and tidal irrigation of the infected pleural cavity with normal saline and antibiotics.3' The overall mortality rate in the collected series,35 12 1520 including the 14 cases reported by Kilman et al in 1969," was less than 7%. The only postoperative death recorded in our 10 patients who had surgery was that of a patient with multiple bilateral aspergillomas who had fatal haemoptysis before completion of staged resection; that gave us an operative mortality of 10%. Parker et a!32 and Varkey and Rose3 recorded a low mortality rate from massive haemoptysis in pulmonary aspergilloma in association with nontuberculous disease. In contrast, Karas et a!20 and Solit et al'5 recorded a 25-100% rate for death from massive haemoptysis in patients who had tuberculosis and coexisting pulmonary aspergillomas.
In conclusion, aspergilloma represents the most common infectious complication of residual pulmonary tuberculous cavities. The most frequent presentation is haemoptysis, which may recur with increasing severity and cause death. We advocate combined preoperative and postoperative antituberculosis drug treatment with surgical resection as a means of forestalling exsanguinating haemorrhage in patients whose clinical condition and pulmonary state do not prohibit operation.
